Relapsing polychondritis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 36: Line 36:




The earliest abnormality of hyaline and elastic cartilage noted histologically is basophilic staining indicating depletion of proteoglycan from the cartilage matrix. Inflammatory infiltrates are found adjacent to involved cartilage and consist predominantly of mononuclear cells and occasional plasma.
Immunologic mechanisms play an important role in the pathogenesis of relapsing polychondritis.Humoral and cell mediated immunity play an important role in the pathogenesis.Immunoglobin and complement deposits are found at sites of inflammation.


The earliest abnormality of hyaline and elastic cartilage noted histologically is basophilic staining indicating depletion of proteoglycan from the cartilage matrix. Inflammatory infiltrates are found adjacent to involved cartilage and consist predominantly of mononuclear cells and occasional plasma.





Revision as of 18:21, 18 November 2012

Relapsing polychondritis
ICD-10 M94.1
ICD-9 733.99
DiseasesDB 10248
eMedicine med/2000  derm/375
MeSH D011081

WikiDoc Resources for Relapsing polychondritis

Articles

Most recent articles on Relapsing polychondritis

Most cited articles on Relapsing polychondritis

Review articles on Relapsing polychondritis

Articles on Relapsing polychondritis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Relapsing polychondritis

Images of Relapsing polychondritis

Photos of Relapsing polychondritis

Podcasts & MP3s on Relapsing polychondritis

Videos on Relapsing polychondritis

Evidence Based Medicine

Cochrane Collaboration on Relapsing polychondritis

Bandolier on Relapsing polychondritis

TRIP on Relapsing polychondritis

Clinical Trials

Ongoing Trials on Relapsing polychondritis at Clinical Trials.gov

Trial results on Relapsing polychondritis

Clinical Trials on Relapsing polychondritis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Relapsing polychondritis

NICE Guidance on Relapsing polychondritis

NHS PRODIGY Guidance

FDA on Relapsing polychondritis

CDC on Relapsing polychondritis

Books

Books on Relapsing polychondritis

News

Relapsing polychondritis in the news

Be alerted to news on Relapsing polychondritis

News trends on Relapsing polychondritis

Commentary

Blogs on Relapsing polychondritis

Definitions

Definitions of Relapsing polychondritis

Patient Resources / Community

Patient resources on Relapsing polychondritis

Discussion groups on Relapsing polychondritis

Patient Handouts on Relapsing polychondritis

Directions to Hospitals Treating Relapsing polychondritis

Risk calculators and risk factors for Relapsing polychondritis

Healthcare Provider Resources

Symptoms of Relapsing polychondritis

Causes & Risk Factors for Relapsing polychondritis

Diagnostic studies for Relapsing polychondritis

Treatment of Relapsing polychondritis

Continuing Medical Education (CME)

CME Programs on Relapsing polychondritis

International

Relapsing polychondritis en Espanol

Relapsing polychondritis en Francais

Business

Relapsing polychondritis in the Marketplace

Patents on Relapsing polychondritis

Experimental / Informatics

List of terms related to Relapsing polychondritis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ,Assistant Editor-in-Chief: Soumya Sachdeva


Overview

Relapsing polychondritis is a condition where cartilage deteriorates.

It is also known as Chronic atrophic polychondritis, Meyenburg-Altherr-Uehlinger syndrome, von Meyenburg's disease, Generalized chondromalacia, or Systemic chondromalacia.

Causes

Reasons for disease onset are not known.

It is considered to possibly be an auto-immune disease[1] in which the human's body's immune system begins to attack and destroy the cartilage tissues in the body.



Pathophysiology

The earliest abnormality of hyaline and elastic cartilage noted histologically is basophilic staining indicating depletion of proteoglycan from the cartilage matrix. Inflammatory infiltrates are found adjacent to involved cartilage and consist predominantly of mononuclear cells and occasional plasma. Immunologic mechanisms play an important role in the pathogenesis of relapsing polychondritis.Humoral and cell mediated immunity play an important role in the pathogenesis.Immunoglobin and complement deposits are found at sites of inflammation.



Diagnosis

Onset

While the disease can come on at various times, most frequent time for onset is in the late 40's to early 50's. Some literature reports a slightly higher occurrence in females than males, while other literature asserts that sex is apparently not a statistically significant factor in the occurrence rate of the disease. Polychondritis is one of many subclasses of disease in the area of Rheumatology.

Presentation

All cartilage areas can be affected, though in many cases the disease will affect several areas where cartilage is found in the body, and leave others entirely alone. Parts of the body with cartilage, and therefore potentially affected by polychondritis, include the ears, nose, throat, heart valves and of course all areas where musculo-skeletal tissues are connected by cartilage. Specific resultant conditions may include Type 3 Tracheomalacia and Vasculitis.

Symptoms

  • Decreased joint mobility
  • Joint erythema
  • Joint inflammation
  • Joint swelling
  • Pain on movement of joint

Differential Diagnosis

  • Cauliflower ear
  • Chondritis
  • Chondromdermatitis
  • Hansen's disease
  • Nodularis helicis
  • Perichondritis
  • Rhinophyma
  • Skin cancer
  • Syphilis

Treatment

Treatment plans typically involve suppression of the immune system with medicines, which often result in a side effect of increasing the risk of other infections.

References

  1. "Relapsing Polychondritis: Autoimmune Disorders of Connective Tissue: Merck Manual Home Edition".

External links


Template:Osteochondropathy Template:Diseases of the musculoskeletal system and connective tissue


de:Polychondritis nl:recidiverende polychondritis


Template:WikiDoc Sources